Jing Han Hong Selected Research

Jing Han Hong Research Topics

8	Neoplasms (Cancer) 03/2024 - 11/2017
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2021
2	Nasopharyngeal Carcinoma 10/2023 - 01/2021
1	Cholangiocarcinoma 11/2023
1	Carcinogenesis 11/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2022
1	Fibroepithelial Neoplasms 04/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2016

3	ChromatinIBA 01/2023 - 11/2017
2	Histone Deacetylase InhibitorsIBA 01/2023 - 01/2022
2	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2023 - 09/2021
1	statticIBA 08/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Polycomb Repressive Complex 2IBA 01/2023
1	InterferonsIBA 11/2022
1	pazopanib FDA Link 04/2022
1	aristolochic acid I (aristolochic acid)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 10/2021
1	trametinibIBA 10/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2021
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	ethyleneIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016

3	Drug Therapy (Chemotherapy) 03/2024 - 01/2021
3	Therapeutics 11/2023 - 01/2022